Cargando…

Arterial stiffness as a model to dissect chronic inflammation in FMF

Detalles Bibliográficos
Autores principales:	Kukuy, O, Leiba, A, Mendel, L, Benor, A, Giat, E, Perski, O, Feld, O, Kessel, Y, Ben Zvi, I, Lidar, M, Livneh, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599843/ http://dx.doi.org/10.1186/1546-0096-13-S1-P93

Ejemplares similares

P01-031 – Anakinra for colchicine resistant FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

Featuring the phenotype of the FMF prototype
por: Ben-Zvi, I, et al.
Publicado: (2015)

P01-029 – Microscopic hematuria in FMF
por: Grabowitz, L, et al.
Publicado: (2013)

Factors affecting cardiovascular morbidity in young FMF patients. A comparative analysis in colchicine treated FMF patients with and without cardiovascular disease
por: Roitman, AJ, et al.
Publicado: (2015)

The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease
por: Giat, Eitan, et al.
Publicado: (2022)

PW01-010 – The effect of pregnancy on disease course in FMF
por: Eviatar, T, et al.
Publicado: (2013)

Over representation of the A allele in the IL23R rs1004819 polymorphism in M694V homozygote non-responsive FMF patients
por: Pras, E, et al.
Publicado: (2015)

Toll like receptor 2 is overexpressed in FMF patients during attacks and inhibited by colchicine treatment
por: Ben-David, H, et al.
Publicado: (2015)

Screening for Fabry’s disease in a high-risk subpopulation of FMF
por: Maller, Tomer, et al.
Publicado: (2022)

P01-033 – Co-occurance of Crohn’s disease and FMF
por: Epstein, A, et al.
Publicado: (2013)

Genetic analysis of MEFV mutation negative familial Mediterranean fever for non-MEFV mutations is rarely effective
por: Ben-Zvi, I, et al.
Publicado: (2015)

P01-030 – Proteinuria in FMF – prediction of nephropathy type
por: Kukuy, OL, et al.
Publicado: (2013)

PReS-FINAL-2328: Developing and validating the new severity score for FMF
por: Demirkaya, E, et al.
Publicado: (2013)

PW01-011 – Exertional leg pain and spondyloarthropathy on FMF
por: Rosman, Y, et al.
Publicado: (2013)

P01-035 – Long-term IV colchicine in oral colchicines failure
por: Feld, O, et al.
Publicado: (2013)

PReS-FINAL-2220: Cochlear involvement in FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2219: Evaluation of autonomic function in FMF
por: Aktay Ayaz, N, et al.
Publicado: (2013)

P01-032 – Characterization of genetic-negative FMF
por: Ben-Zvi, I, et al.
Publicado: (2013)

Assessment of the pathogenicity of the p.K695R and p.A744S Mediterranean fever gene variants
por: Shinar, Y, et al.
Publicado: (2015)

The clinical phenotype of Israeli patients with Q703K mutation in the NLRP3 gene
por: Lidar, M, et al.
Publicado: (2015)

Quality of life changes with canakinumab therapy in adults with colchicine resistant FMF
por: Gul, A, et al.
Publicado: (2015)

How long is the diagnosis of Familial Mediterranean Fever (FMF) delayed in a region where FMF is common in Turkey?
por: Karaaslan, Y, et al.
Publicado: (2015)

Epidemiology of colchicine resistant Familial Mediterranean Fever disease (CrFMF) in Turkey
por: Turgay, S, et al.
Publicado: (2015)

Validity and reliability of medication adherence scale in FMF
por: Fidanci, BE, et al.
Publicado: (2015)

PReS-FINAL-2213: Validation of inadequate drug response and definition of colchicum resistance in FMF
por: Demirkaya, E, et al.
Publicado: (2013)

Developing of a new scale for assessing the adherence to colchicine treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2015)

PReS-FINAL-2222: FMF presenting with the features of malignancy
por: Keskindemirci, G, et al.
Publicado: (2013)

PReS-FINAL-2221: An earliest diagnosis of FMF
por: Keskindemirci, G, et al.
Publicado: (2013)

Coexistence of PFAPA syndrome and FMF in Armenian children
por: Mkrtchyan, N, et al.
Publicado: (2015)

Profile of cytokines, growth factors and chemokines during attacks of FMF
por: Bilginer, Y, et al.
Publicado: (2008)

PReS-FINAL-2227: QT and JT dispersion in children with FMF
por: Fidanci, K, et al.
Publicado: (2013)

The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)
por: Wittkowski, H, et al.
Publicado: (2008)

PReS-FINAL-2204: Developing of a new scale for assessing the adherence to colchicines treatment in pediatric patients with FMF
por: Yesilkaya, S, et al.
Publicado: (2013)

Anakinra for secondary amyloidosis in an adolescent with FMF and Behcet Disease
por: Bilginer, Y, et al.
Publicado: (2008)

A child with cPAN as only manifestation of FMF
por: Khloyan, Gayane, et al.
Publicado: (2014)

Acute phase reactants in the follow-up of patients with FMF
por: Arıcı, ZS, et al.
Publicado: (2015)

How safe it is to treat pregnant FMF patients with Anakinra?
por: Ozdogan, H, et al.
Publicado: (2015)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Clinical and subclinical features and MEFV mutation distribution in of FMF patients’ siblings
por: Gunduz, Z, et al.
Publicado: (2015)

Attacks of severe dysmenorrhea as the sole manifestation of Familial Mediterranean Fever (FMF)
por: Vitale, A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_g7335qok7gemdku16rchb1l6m5